Skip to content
About SpectraCure
Strategy
Market Overview
Clinical Studies
The Product
Method
Patent
Newsroom
Press releases
News
Investor letter
Media bank
Investor
Financial reports
Financial calendar
Owners
The share
Certified adviser
Prospectus
Governance
Governance report
Articles of Association
General meetings
Nomination committee
Board
Auditor
Management
Contact
Career
About SpectraCure
Strategy
Market Overview
Clinical Studies
The Product
Method
Patent
Newsroom
Press releases
News
Investor letter
Media bank
Investor
Financial reports
Financial calendar
Owners
The share
Certified adviser
Prospectus
Governance
Governance report
Articles of Association
General meetings
Nomination committee
Board
Auditor
Management
Contact
Career
SV
EN
Press releases
Start
/
Newsroom
/
Press releases
Press releases
News
Investor letter
Media bank
Press releases
News
Investor letter
Media bank
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2020
2020-03-06 11:30
Agreement reached between SpectraCure and one more hospital - Memorial Sloan Kettering Cancer Center i n New York
Regulatory
MAR
2020-02-25 12:00
Year End Report 2019
Regulatory
MAR
2020-02-24 11:30
Reinforcements in SpectraCure's organization
Regulatory
2020-01-17 14:50
A welcome addition to support our ongoing product development. SpectraCure receives research contribution from the EU.
Regulatory
2019
2019-12-04 09:15
Exercise rate of 98.8 percent for SpectraCure's warrants (TO3)
Regulatory
MAR
2019-11-26 15:56
Last day of trading of SPEC TO3 subscription warrants tomorrow, Nov. 27
Regulatory
2019-11-13 14:20
SpectraCure´s main owner subscribes in full for his share
Regulatory
2019-11-12 14:00
SpectraCure AB Quarterly Report (1 July to 30 September) 2019
Regulatory
MAR
2019-10-28 11:10
The FDA's initiative can provide faster market access for SpectraCure
Regulatory
MAR
2019-10-16 11:02
SpectraCure at Stora Aktiedagen in Gothenburg
Regulatory
Previous
Next